 In 2009 , Pfizer paid $ 2 @.@ 3 billion and entered a corporate integrity agreement to settle charges that it had <unk> and illegally promoted four drugs , and caused false claims to be submitted to government healthcare programs for uses that had not been approved by the United States Food and Drug Administration . $ 1 @.@ 3 billion was paid to settle criminal charges of illegally marketing the anti @-@ inflammatory <unk> , while $ 1 billion was paid in civil fines regarding illegal marketing of three other drugs , including Zyvox . 
